MCM
EXAS

McKinley Capital Management’s Exact Sciences EXAS Stock Holding History

McKinley Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,070
Closed -$2.49M – 130
2024
Q1 		$2.49M Hold
36,070
– – 0.3% 92
2023
Q4 		$2.67M Buy
36,070
+12,770
+55% +$837K 0.34% 86
2023
Q3 		$1.59M Hold
23,300
– – 0.22% 106
2023
Q2 		$2.19M Buy
+23,300
New +$1.82M 0.29% 98

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

McKinley Capital Management's EXAS Position: Q2 2024 in Review

McKinley Capital Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 36,070 shares — an estimated $2.49M sold.

McKinley Capital Management first reported a position in EXAS in Q2 2023 and held it in 4 quarters. The position peaked at $2.67M in Q4 2023. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • McKinley Capital Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • McKinley Capital Management sold 36,070 Exact Sciences shares in Q2 2024, an estimated $2.49M.
  • McKinley Capital Management first reported a position in Exact Sciences in Q2 2023 and held it in 4 quarters.
  • McKinley Capital Management's Exact Sciences position peaked at $2.67M in Q4 2023.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.